New user? / Forgot your password?
0 Item | 0,00 €
Sotalol Hydrochloride Unmatched Purity for Precise Residue Analysis
Ensure the highest accuracy in your residue analysis with HPC Standards GmbHs high-purity reference materials for Sotalol Hydrochloride. Our products are rigorously tested to meet international quality requirements and the highest industrial standards, making them indispensable for laboratories focused on food and environmental analysis. Trust HPC Standards GmbH as your competent partner in achieving compliance with regulatory limits.
Product | Catalog No./ CAS No. | Quantity | Price | |
---|---|---|---|---|
681163 | 1X10MG | Please log in. | ||
D7-Sotalol hydrochloride solution | 690932 | 1X1ML | Please log in. | |
679337 | 1X100MG | Please log in. | ||
Sotalol hydrochloride solution | 684735 | 1X1ML | Please log in. |
High-purity reference materials for accurate residue analysis.
Sotalol hydrochloride is a medication primarily used to treat and prevent abnormal heart rhythms. It is a non-selective beta-blocker with both class II and class III antiarrhythmic properties.
Sotalol is used to maintain a normal heart rhythm in people with life-threatening ventricular arrhythmias, such as ventricular tachycardia, or very symptomatic atrial fibrillation or flutter. It is also used off-label for essential tremor.
Sotalol hydrochloride is a prescription-only medication in many countries, including Australia (S4), Canada (Rx-only), the UK (POM), and the US (Rx-only).
Due to the risk of serious side effects, patients starting or restarting sotalol must be hospitalized for at least three days in a facility that can provide cardiac resuscitation and continuous electrocardiographic monitoring.
Common side effects include slow heart rate, chest pain, low blood pressure, dizziness, shortness of breath, and swelling. Serious side effects may include QT prolongation, heart failure, or bronchospasm.
Information on the environmental impact of sotalol hydrochloride on wildlife is limited and requires further research to determine specific effects.
Patients with a waking heart rate lower than 50 beats per minute, long QT syndrome, or uncontrolled heart failure should not use sotalol. It should also be avoided in individuals with severe kidney impairment or those who are breastfeeding.
Sotalol hydrochloride is regulated by various health authorities, including the FDA, which mandates strict guidelines for its use due to potential risks.
HPC Standards GmbH provides high-purity reference materials for sotalol hydrochloride, ensuring accurate and reliable residue analysis. These materials meet international quality requirements and the highest industrial standards, essential for laboratories conducting food and environmental analysis.